Latest Investment Outlook News

Qualitas Limited reported a robust 36% increase in normalised net profit before tax for FY25, driven by strong fee growth and principal income, while guiding for further growth in FY26. The company’s expanding private credit focus and ESG initiatives position it well amid evolving market conditions.

Telix Pharmaceuticals reported a robust 63% revenue increase in H1 2025, driven by commercial growth and strategic investments, while advancing key clinical trials and maintaining full-year guidance.

Metal Bank Limited is fast-tracking gold production at its Livingstone project in Western Australia, leveraging near-surface resources and existing processing infrastructure, while advancing copper and critical minerals exploration in Saudi Arabia.

Knosys Limited sustains a robust $9.8 million Annual Recurring Revenue, extends its ANZ Bank contract, and accelerates AI-driven library technology development with promising early market feedback.

Rand Mining Ltd reported solid gold production of 8,916 ounces in the June 2025 quarter, alongside improved cash flow and ongoing exploration success at key Western Australian projects.

Terramin Australia reports steady progress across multiple projects including key drilling at Tala Hamza and regulatory approvals at Kapunda, while navigating legal challenges at Bird in Hand. Algeria’s recent mining reforms offer a promising backdrop for the company’s expansion plans.

Oneview Healthcare reported a €4 million cash outflow in Q2 2025, driven by restructuring and lower R&D credits, while securing new US hospital contracts and expanding AI-powered care solutions.

Bastion Pte. Mining Ltd has secured an 86.8% interest in Xanadu Mines, prompting the board to recommend shareholders accept the takeover offer ahead of its extended July 29 closing date.

Mirrabooka Investments Limited has announced a 1-for-7 entitlement offer priced at $3.06 per share, aiming to raise approximately $85 million to capitalize on emerging investment opportunities.

Powerhouse Ventures Limited reports a robust start to 2025, highlighted by strong fund performance, a successful capital raise, and strategic business expansion despite market volatility.

XRF Scientific Limited reported a robust half-year performance ending December 2024, with revenue edging up 0.3% to $28.7 million and net profit after tax surging 11.8% to $5.0 million, driven by strong consumables sales and international growth.

GPT Management Holdings Limited reported a substantial net loss of $40.6 million for the year ended December 31, 2024, despite a 31.7% increase in total revenues to $340 million. No dividends were declared, signaling a cautious outlook amid challenging conditions.